As PTCH1 may shuttle between the cell membrane and endocytotic vesicles in response to active hedgehog ligand, it is obvious that not only its mRNA expression, but also its protein expression (at the relevant location, binding of SMO, etc.)is necessary to exert its tumour suppressor activity [21]. The gene discussed is SMO; the disease is neoplasm.